The Incyte Ingenuity Awards aim to provide funding to support innovative initiatives annually that address specific needs for people impacted by serious diseases, such as GVHD and vitiligo, including patients and their providers.
The Incyte Ingenuity Awards in GVHD have been supporting the GVHD community since 2020 and are currently offering two awards – one for an initiative up to $35,000 and another for an initiative up to $100,000.
The 2023 program is now open for applications! Click here to learn about eligibility and how to apply.
The Incyte Ingenuity Awards in Dermatology launched in 2022. Click here to learn more about these Awards.
Programs must be independent of any ongoing activities, with the exception of considerably expanding an existing program. Additionally, programs cannot include indirect costs with the proposed budget. To be eligible, you and your organization must be US based (including Washington DC and Puerto Rico).
Applications will be disqualified if:
- Focus is on a particular therapeutic agent, translational research, or clinical research that is interventional in nature.
- Organization is improperly identified as a 501(c)(3) organization.
- Application is submitted by a healthcare professional as an individual (individuals will need to partner with a not-for-profit or other organization to be considered).
- Defined scope does not serve or plan to address a specific need of the GVHD community.
- Request in funding exceeds 25% of an organization’s overall funding and/or includes indirect costs.
- Application is submitted by an employee of Incyte, VOZ Advisors, and/or other vendors, or members of the immediate family of any such persons.
- Program is duplicated, with multiple copies of an application submitted by the same organization.
- Program exceeds the maximum application limit per organization (more than five).
- Program is based on an existing initiative, with no evidence of ingenuity.
Incyte reserves the right to modify the eligibility requirements at any time.